124 related articles for article (PubMed ID: 37890328)
1. Generation and characterization of iPS cell line (SYSUSHi002-A) from PBMCs of an AML patient with TP53 mutation.
Yuan L; Wang Y; Xie R; Lin D; Wang X
Stem Cell Res; 2023 Dec; 73():103230. PubMed ID: 37890328
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of iPS cell line (CTGUi001-A) from skin fibroblasts of a patient with Fabry disease.
Qin Y; Zhan JQ; Ma CJ; Cao CY; Zhang Y; Min YT; Lv YF
Stem Cell Res; 2023 Jun; 69():103063. PubMed ID: 36917862
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of the iPS cell line (SYSUSHi001-A) derived from the peripheral blood mononuclear cells (PBMCs) of a 33-year-old patient with acute myeloid leukemia (AML).
Yuan L; Xie M; Tao Y; Chen X; Xu X; Wang X
Stem Cell Res; 2024 Feb; 77():103360. PubMed ID: 38608356
[TBL] [Abstract][Full Text] [Related]
4. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
5. Generation of a human iPSC line (HIMRi001-A) from a patient with filaminopathy.
Daya NM; Mavrommatis L; Zhuge H; Athamneh M; Roos A; Gläser D; Doering K; Zaehres H; Vorgerd M; Güttsches AK
Stem Cell Res; 2023 Oct; 72():103210. PubMed ID: 37748332
[TBL] [Abstract][Full Text] [Related]
6. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11.
Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
Stem Cell Res; 2016 May; 16(3):553-6. PubMed ID: 27346190
[TBL] [Abstract][Full Text] [Related]
7. Episomal plasmid-based generation of an iPSC line from a 79-year-old individual carrying the APOE4/4 genotype: i11001.
Zulfiqar S; Fritz B; Nieweg K
Stem Cell Res; 2016 Nov; 17(3):544-546. PubMed ID: 27789405
[TBL] [Abstract][Full Text] [Related]
8. Generation of induced pluripotent stem cell (iPSC) line from Charcot-Marie-Tooth disease patient with MPZ mutation (CMT1B).
Son D; Kang PJ; Yun W; You S
Stem Cell Res; 2017 Oct; 24():5-7. PubMed ID: 29034895
[TBL] [Abstract][Full Text] [Related]
9. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.B11.
Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
Stem Cell Res; 2016 May; 16(3):589-92. PubMed ID: 27346191
[TBL] [Abstract][Full Text] [Related]
10. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a L150P mutation in PSEN-1.
Tubsuwan A; Pires C; Rasmussen MA; Schmid B; Nielsen JE; Hjermind LE; Hall V; Nielsen TT; Waldemar G; Hyttel P; Clausen C; Kitiyanant N; Freude KK; Holst B
Stem Cell Res; 2016 Jan; 16(1):110-2. PubMed ID: 27345792
[TBL] [Abstract][Full Text] [Related]
11. Generation of the human induced pluripotent stem cell line PUMCi005-A from a patient with Perrault syndrome.
Wang YB; Lv YF; Zhang Y; Wang W
Stem Cell Res; 2024 Mar; 75():103318. PubMed ID: 38295749
[TBL] [Abstract][Full Text] [Related]
12. Establishment of induced pluripotent stem cell line SDPHi003-A from a healthy male donor.
Xi Y; Zhang H; Yang X; Ai D; Liu Y; Song W
Stem Cell Res; 2023 Sep; 71():103160. PubMed ID: 37429069
[TBL] [Abstract][Full Text] [Related]
13. Generation of induced pluripotent stem cell (iPSC) line from a 36-year-old Charcot-Marie-Tooth disease patient with GJB1 mutation (CMTX).
Son D; Kang PJ; Yun W; You S
Stem Cell Res; 2017 May; 21():9-12. PubMed ID: 28677541
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a transgene-free iPS cell line (SDCHi003-A) from a young patient bearing a NPRL2 mutation and suffering from Epilepsy.
Su S; Zhao F; Zhang H; Liu Y; Li Z; Zhang H; Wang Y; Fang F; Liu Y
Stem Cell Res; 2024 Apr; 76():103366. PubMed ID: 38430737
[TBL] [Abstract][Full Text] [Related]
15. Generation of a human iPSC line (MPIi007-A) from a patient with Metachromatic leukodystrophy.
Kim KP; Yoon J; Kim J; Röpke A; Shin B; Wook Han D; Greber B; Schöler HR
Stem Cell Res; 2020 Oct; 48():101993. PubMed ID: 32950023
[TBL] [Abstract][Full Text] [Related]
16. Generation of an induced pluripotent stem cell line SDPHi002-A from a patient with lung cancer.
Ai D; Yang X; Li X; Liu N; Xie X; Liu Y; Song W
Stem Cell Res; 2023 Jun; 69():103096. PubMed ID: 37104933
[TBL] [Abstract][Full Text] [Related]
17. Generation of a human iPSC line (MPIi006-A) from a patient with Pelizaeus-Merzbacher disease.
Kim KP; Yoon J; Shin B; Röpke A; Han DW; Schöler HR
Stem Cell Res; 2020 Jul; 46():101839. PubMed ID: 32446239
[TBL] [Abstract][Full Text] [Related]
18. Establishment of DYT5 patient-specific induced pluripotent stem cells with a GCH1 mutation.
Murakami N; Ishikawa T; Kondo T; Imamura K; Tsukita K; Enami T; Funayama M; Shibukawa R; Matsumoto S; Izumi Y; Ohta E; Obata F; Kaji R; Inoue H
Stem Cell Res; 2017 Oct; 24():36-39. PubMed ID: 29034893
[TBL] [Abstract][Full Text] [Related]
19. Derivation of induced pluripotent stem cells from a familial Alzheimer's disease patient carrying the L282F mutation in presenilin 1.
Poon A; Li T; Pires C; Nielsen TT; Nielsen JE; Holst B; Dinnyes A; Hyttel P; Freude KK
Stem Cell Res; 2016 Nov; 17(3):470-473. PubMed ID: 27789396
[TBL] [Abstract][Full Text] [Related]
20. Generation and characterization of a genetic Parkinson's disease-patient derived iPSC line DJ-1-delP (LCSBi008-A).
Mencke P; Boussaad I; Önal G; Kievit AJA; Boon AJW; Mandemakers W; Bonifati V; Krüger R
Stem Cell Res; 2022 Jul; 62():102792. PubMed ID: 35500378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
